Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers — Roche Diagnostics Corp. (PMA P000027)
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers — Roche Diagnostics Corp. (PMA P000027) is one of 9,000 device clearances in the DeviceClear dataset. Key details — Device name: Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers; Applicant: Roche Diagnostics Corp.; Clearance track: PMA
| Device name | Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers |
|---|---|
| Applicant | Roche Diagnostics Corp. |
| Clearance track | PMA |
| Submission number | P000027 |
| Decision | OK30 |
| Decision date | 2017-06-23 |
| Date received | 2017-05-24 |
| Product code | LTJ |
| Device class | 2 |
| Medical specialty | Immunology |
| Applicant location | IN |
| Source | openFDA device |
🔍 Search all device clearances →
$1999/mo
Try DeviceClear →